Quantcast
Last updated on April 24, 2014 at 11:16 EDT

Latest Low-density lipoprotein Stories

2013-12-23 23:22:37

The new “Foods To Reduce Cholesterol” article written by Peter Schiff on the website Healthreviewcenter.com teaches people how to balance cholesterol level naturally. Seattle, Wa (PRWEB) December 23, 2013 The brand new ”Foods To Reduce Cholesterol” article penned by Peter Schiff on the website Healthreviewcenter.com delivers to people nutrition advice to decrease cholesterol level safely. This report is specifically designed for those men and women who want to keep their...

Weight Loss Middle-Aged Women Health Benefits
2013-12-20 11:02:34

redOrbit Staff & Wire Reports - Your Universe Online Middle-aged women who are overweight or obese could reduce the risk factors associated with diabetes and heart disease by losing at least 10 percent of their body weight over a 24 month period, according to research appearing in the latest edition of the Journal of the American Heart Association. Dr. Cynthia A. Thomson, a professor at the University of Arizona’s Mel and Enid Zuckerman College of Public Health, and her colleagues...

2013-12-19 08:28:17

Study Meets Primary Endpoint of LDL Cholesterol Reduction THOUSAND OAKS, Calif., Dec. 19, 2013 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the Phase 3 DESCARTES (Durable Effect of PCSK9 Antibody CompARed wiTh PlacEbo Study) study evaluating the long-term 52-week safety and efficacy of evolocumab for the treatment of high cholesterol met its primary endpoint of percent reduction from baseline in low-density lipoprotein cholesterol (LDL-C) at week 52. The mean percent...

2013-12-18 23:28:52

The Long Island law firm of Rudolph F. X. Migliore has announced that the firm is investigating claims of post-menopausal women who developed new on-set Type 2 diabetes after taking the popular statin drug, Lipitor. Commack, New York (PRWEB) December 18, 2013 The Commack, NY law firm Rudolph F. X. Migliore, P.C. has announced the firm is now accepting cases on behalf of post-menopausal women who have taken the prescription drug Lipitor and later developed new on-set Type 2 diabetes....

2013-12-19 00:20:33

Collaboration represents the first time the ACC's PINNACLE Registry Research Alliance will be used for clinical trial recruitment PARIS and TARRYTOWN, N.Y., Dec. 19, 2013 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced an innovative collaboration with the American College of Cardiology (ACC) focused on enhancing clinical research with alirocumab, an investigational monoclonal antibody targeting PCSK9 (proprotein...

2013-12-17 08:30:23

Study Meets Co-Primary Endpoints of LDL Cholesterol Reduction THOUSAND OAKS, Calif., Dec. 17, 2013 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the Phase 3 MENDEL-2 (Monoclonal Antibody Against PCSK9 to Reduce Elevated LDL-C in Subjects Currently Not Receiving Drug Therapy for Easing Lipid Levels-2) trial with evolocumab met its co-primary endpoints: the percent reduction from baseline in low-density lipoprotein cholesterol (LDL-C) at week 12 and the mean percent reduction from...

2013-12-11 23:28:30

Sancilio and Company, Inc. (SCI) today announced its submission of an investigational new drug (IND) application to the U.S. Food and Drug Administration (FDA) for a pivotal Phase 3 study of its lead investigational drug, SC401™. SC401 is a combination of highly refined eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) formulated with SCI’s proprietary Advanced Lipid Technology™ platform to enhance bioavailability, eliminate the significant food effect exhibited by EPA/DHA...

Corn Oil Better At Reducing Cholesterol
2013-12-07 06:23:03

April Flowers for redOrbit.com - Your Universe Online A new study reveals that corn oil significantly reduces cholesterol with more favorable changes in total cholesterol (TC) and LDL-C than extra virgin olive oil. Dr. Kevin C. Maki, of Biofortis, the clinical research arm of Mérieux NutriSciences, presented the study findings at the American Society for Nutrition's Advances & Controversies in Clinical Nutrition Conference earlier this week. The study was comprised of 54 healthy...

2013-12-05 08:29:55

CAMBRIDGE, Mass., Dec. 5, 2013 /PRNewswire/ -- Catabasis Pharmaceuticals, Inc., today announced the initiation of a Phase 2 clinical trial investigating the safety and efficacy of CAT-2003 in patients with severe hypertriglyceridemia, defined as serum triglyceride levels of 500 mg/dL or greater. CAT-2003 is a conjugate of niacin and the omega 3 fatty acid, eicosapentaenoic acid (EPA), employing Catabasis' proprietary SMART Linker technology. In this second Phase 2 trial of CAT-2003,...

2013-12-03 08:34:15

FOLSOM, Calif., Dec. 3, 2013 /PRNewswire/ -- A new study published in Metabolism indicates a diet with walnuts may reduce cardiovascular disease risk by lowering non-HDL cholesterol(1) and apolipoprotein B(2) (ApoB) - two predictors of cardiovascular disease risk. Researchers at University of Munich Medical Center, Germany investigated the effects of daily walnut consumption (43 grams/1.5 ounce) on blood lipid levels that predict cardiovascular disease risk, and found non-HDL cholesterol...